The Clonal Origin and Clonal Evolution of Epithelial Tumours
Overview
Authors
Affiliations
While the origin of tumours, whether from one cell or many, has been a source of fascination for experimental oncologists for some time, in recent years there has been a veritable explosion of information about the clonal architecture of tumours and their antecedents, stimulated, in the main, by the ready accessibility of new molecular techniques. While most of these new results have apparently confirmed the monoclonal origin of human epithelial (and other) tumours, there are a significant number of studies in which this conclusion just cannot be made. Moreover, analysis of many articles show that the potential impact of such considerations as patch size and clonal evolution on determinations of clonality have largely been ignored, with the result that a number of these studies are confounded. However, the clonal architecture of preneoplastic lesions provide some interesting insights --many lesions which might have been hitherto regarded as hyperplasias are apparently clonal in derivation. If this is indeed true, it calls into some question our hopeful corollary that a monoclonal origin presages a neoplastic habitus. Finally, it is clear, for many reasons, that methods of analysis which involve the disaggregation of tissues, albeit microdissected, are far from ideal and we should be putting more effort into techniques where the clonal architecture of normal tissues, preneoplastic and preinvasive lesions and their derivative tumours can be directly visualized in situ.
Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development.
Schoultz E, Johansson E, Moccia C, Jakubikova I, Ravi N, Liang S Dis Model Mech. 2021; 15(2).
PMID: 34379110 PMC: 8380047. DOI: 10.1242/dmm.048887.
Challenges and Opportunities in NUT Carcinoma Research.
Hakun M, Gu B Genes (Basel). 2021; 12(2).
PMID: 33562801 PMC: 7915910. DOI: 10.3390/genes12020235.
The cellular origins of cancer with particular reference to the gastrointestinal tract.
Alison M Int J Exp Pathol. 2020; 101(5):132-151.
PMID: 32794627 PMC: 7495846. DOI: 10.1111/iep.12364.
Zhong L, Liu Y, Wang K, He Z, Gong Z, Zhao Z BMC Cancer. 2018; 18(1):911.
PMID: 30241505 PMC: 6151070. DOI: 10.1186/s12885-018-4806-7.
Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.
Sinha V, Piwnica-Worms H J Mammary Gland Biol Neoplasia. 2018; 23(4):191-205.
PMID: 30194658 PMC: 6934090. DOI: 10.1007/s10911-018-9410-6.